Alzheimer's and Parkinson's charities identify new ways to reuse current drugs

Experts say that by repurposing drugs, they can 'increase the shots on target' at tackling the diseases.
This method of drug development could also reduce the time patients are left waiting for new treatments by up to 10 years, they added.
It comes after the NHS spending watchdog rejected the use of new Alzheimer's drugs lecanemab and donanemab for widespread use in the health service.
The drugs were approved for use in the UK last year by the UK's medicines regulator but the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), said they could not be used in the NHS because the benefits are 'too small' to justify the cost.
Now charities Cure Parkinson's and Alzheimer's Research UK have joined forces to find current drugs that may tackle some of the common biology behind both diseases.
https://x.com/AlzResearchUK/status/1929856926885539966/photo/2
After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson's over a decade ago, experts from both fields will select the most promising drugs for both Parkinson's and dementia, so they can be moved quickly into clinical trials.
Weight loss jabs are already being investigated for their effectiveness in treating symptoms of both diseases and experts hope to uncover more drugs that can have multiple uses.
Semaglutide, the active ingredient for weight loss and diabetes drugs Wegovy and Ozempic, is being examined in clinical trials to see whether it can help patients with Alzheimer's disease or Parkinson's.
Trial results for the Alzheimer's trial are expected to be published later this year.
Dr Sheona Scales, director of research at Alzheimer's Research UK, told the PA news agency that the iLCT project had already been 'hugely successful' with people who have Parkinson's, adding: 'Around 30% of disease modifying therapies that are in clinical trials for Parkinson's disease came through this process.
'What we wanted to do is to build on their knowledge and experience and expertise in order to be able to bring a process similar to that to Alzheimer's disease.'
Dr Scales said that there are some 'common grounds' between Parkinson's and Alzheimer's – both are neurodegenerative diseases and have some 'common biological processes' – such as inflammation, mitochondrial dysfunction and 'protein misfolding' – which could be targets for repurposed drugs.
'Getting multiple drugs that are targeting the disease is really important to us,' she said.
'Testing different types of drugs and getting as many shots on target is important.'
She said: 'Repurposed drugs have already been demonstrated to be safe for use in humans development of new drugs for different diseases is a long process.
'What essentially bringing repurposed drugs does, is help to accelerate the drug development pipeline – it could save between five and 10 years within that process, compared to taking a new drug through clinical trials for the very first time.'
Helen Matthews, chief executive of Cure Parkinson's, said the iLCT was originally set up to identify drugs that can potentially 'slow down, stop or reverse Parkinson's'.
She added: 'It was through this programme that we realised that there were so many drugs that were also being looked at in the dementia field and there were commonalities there in terms of the drugs looking to reduce inflammation, or whatever it might be, there were specific pathways that those drugs were working on that could be beneficial for both disease areas.
'So given that we were already doing the (work) every year, it made sense to join forces in this way, just to add efficiencies.
'Because if you're looking at the same drugs, we'll only do that digging once, you know, only do that compilation of the dossiers once, so that you can actually take the learning for both diseases and then actually look and see which might be beneficial.'
She said that the 'sharing of knowledge and digging' could also be shared with other disease areas, such as MS.
And on lecanemab and donanemab, Dr Scales added: '(These) were the first disease-targeting therapies that have been licensed in the UK, but obviously are not available on the NHS at the moment.
'They showed for the very first time that we were able to alter the course of the disease.
'And what we're looking forward to now is what the next generation of treatments can bring us and how we can target different parts of the disease.'
Dr Lucy Devendra, head of research at Alzheimer's Society, said: 'Repurposing medicines which are already known to be safe can help us find new treatments for the diseases that cause dementia much quicker.
'Although it is still early days, it's encouraging to see a renewed focus on this type of research and development.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

BBC News

41 minutes ago

• BBC News

NI health: Woman was asked to examine husband to confirm he was dead

A grieving woman who was told to examine her husband to confirm he was dead says it remains in her mind every time she closes her Catherine Steele's husband Anthony died from stomach cancer in May she called an ambulance but was told none were was asked to make a video call and check her husband's vital signs to confirm he had Northern Ireland Ambulance Service apologised and said: "We are sorry that she did not experience the level of service that she would rightly expect at this particularly difficult time." Video call Mrs Steele had phoned a 24-hour district nurse helpline, but she said no one picked sister then rang the ambulance Steele's sister was told an ambulance would be sent out but none sister then had to leave to pick up Mrs Steele's son from work, leaving her alone with her Steele later received a call to say an ambulance would not be arriving and was asked to take part in a video call."I had to do his pulse on his wrists, and on his neck and then I had to open his eyes up on the video call so she could see," Mrs Steele told BBC Radio Ulster's Nolan was then the medical professional on the call confirmed Mrs Steele's husband was dead. She was asked to contact a doctor, who sent out the district nurse."It's just my last memory of him and it's just in my mind every time I close my eyes," she said."It's not acceptable, I know the ambulance service and NHS is under stress but I just feel it should never happen again."I don't want this to happen to anybody".Mrs Steele said she had been prescribed sleeping tablets due to suffering from insomnia since the incident."I just close my eyes and see his eyes, and it just replays back and back and back on your mind." In a statement, the NIAS said: "We will contact Mrs Steele to arrange to meet her and apologise to her in person and, more importantly, to listen to her concerns that we might learn from her experience to help ensure that no-one else would have to go through the same."

Times

an hour ago

• Times

I won't be shamed for having an elective c-section — trust me, it wasn't easy

Readers, I have a bone to pick. With myself. In my first dispatch here, written when my son was 12 weeks old, I told you that it was 'fine to take shortcuts' and under that umbrella included 'having a c-section'. Oh dear. Even while still nursing a very sore scar and after months of replying 'because I want one' to NHS midwives and obstetricians who asked 'and why do you want a caesarean?', I had still internalised the message that it's somehow 'cheating'. So let me set the record straight: I had an elective c-section and, given the experiences of other women I know — some of whom still can't talk about their births years later — I'd do the same thing again in a heartbeat. But it really wasn't a shortcut. I don't want to sugarcoat it: this is major surgery and my recovery was slow, painful and reliant on painkillers (I was taking codeine on and off for three weeks, when I'd expected maybe one). I had to inject my stomach with anti-clotting drugs for ten days afterwards. Still no regrets. • I'm not breastfeeding. Why are mothers still pressured into it? That's me. I have no interest in playing different types of birth off against one another. But what I do want to talk about is how we're letting women down by withholding information, conflating facts and scaremongering, where we should be doing everything in our power to inform and reassure. Take the new Nice guidance, published this week and designed to improve care for women having caesareans. One minor problem: it conflates the data for planned c-sections and emergency ones. And, as any woman who's had the latter (often after many hours of excruciating and exhausting labour in the pursuit of a vaginal birth) will tell you, there's a bloody world of difference. Lumping the two together is unfair and skews the statistics — for example that one in 25,000 vaginal deliveries ends in maternal death, compared to one in 4,000 for caesareans. Except that includes emergency caesareans, where the mother or baby is in distress and already at risk. For crying out loud. Nice has explained that it's too difficult to separate the two, but frankly I'd rather it didn't publish any numbers than ones that could confuse women even more. How about properly informing parents-to-be, rather than scaring them? It plays directly into the stigma that still exists around choosing a caesarean — that you're entitled and happy to put your baby at risk. A pal admitted to me that before having her daughter, by emergency c-section, she might have judged other women for actively choosing that type of birth. 'Of course, I feel ridiculous now,' she said. I don't blame her. We're rarely told another story, one that says planned caesareans — while not a walk in the park — are at least, all being well, more predictable. I arrived at the hospital feeling calm, my Spotify playlist prepped, happy in the knowledge that my baby would be lying on my chest about 30 minutes after the anaesthetist said: 'Can you feel that?' After two decades of suffering thanks to undiagnosed endometriosis and adenomyosis, I wanted some control over how I gave birth. Yet even I felt a bit embarrassed and felt I had to explain to anyone who asked. When I was eventually told that, a) it would actually be more sensible to have a caesarean given my health conditions, and b) that the baby was breech, meaning he couldn't come out via the traditional route anyway, I felt a wave of relief. Now I had a proper excuse as to why I needed a caesarean and didn't just want one. Looking back, I find it sad that I felt that way. • My painful battle to have the 'unnatural' birth I wanted Out of eight women in my antenatal class, two of us planned caesareans. We spent most of the sessions eye-rolling at each other across the room as our tutor focused on 'normal' birth (the worst term imaginable if you're not having one), and pretty much ignored us, aside from a few minutes spent playing with tiny plastic dolls to demonstrate how many people would be in the room during our surgery. Translation: heavily medicalised and 'unnatural' birth, which also happens to be more expensive for the NHS. And yet. Out of those eight women, seven ended up having caesareans — five emergencies. No wonder they now feel furious that they weren't better equipped to cope. It might be anecdotal, but it's also not unusual from where I'm sitting. A friend tells me that out of the eight women in her antenatal group, every single one of them ended up having caesareans. Off the top of my head, I can think of four electives among my wider social circle and upwards of 20 emergencies. According to NHS Digital, 46 per cent of all the births in England last September were vaginal and 44 per cent were c-section (the other 10 per cent involved instruments). So what exactly is a 'normal' birth now? Officially, the NHS has moved away from its target-led pushing of vaginal birth over caesarean and most women I know haven't had to fight to get one. But what seems more common is uncertainty around when those c-sections might actually take place — time not really being all that flexible at the end of a pregnancy. The NHS says you'll get a date two weeks in advance, with the surgery planned from your 39th week onwards. Hmm. One pal was told the hospital could call her the day before — would that be OK? Another currently has hers scheduled for the end of the week and is terrified by the prospect that she'll be pushed down the list and have to wait until the following Monday. Me? I got a call from the birthing unit to book mine when I was already 38 weeks and three days (having not been booked in, I'd moved my care elsewhere at the last minute). • Natural birth v caesarean — what the latest statistics tell us I know the NHS is stretched but, as one friend put it, it's like they're delaying in the hopes you go into labour and they don't have to pay. For any woman who's been trying to book in for the best part of nine months, it's a nervy prospect, a bit like relying on the Glastonbury resale to get a ticket. Look, I don't want to scare anyone. I hope I haven't. The biggest problem we have is how petrified we make mothers-to-be, or those who haven't yet made up their minds about starting a family. But we're letting women down if we don't tell them the truth: that whatever birth you want is the right birth for you — just also make a plan A, B or C. After all, babies tend not to behave as you want them to, even before they've been born.

Cambrian News

an hour ago

• Cambrian News

Gobsmacked: The sad state of our NHS dentistry

'I have now got two teeth that need attention,' she says. 'One has a temporary filling done privately at extortionate cost and where I felt they just wanted me to pay for unnecessary treatment. I was very uncomfortable and won't go back. I have now approached another dentist as I have a broken tooth on the other side. They come recommended and I'm waiting for an appointment but dreading the bill. NHS dentistry in Ceredigion is non-existent and the private costs are beyond the reach of the majority. The situation is a disgrace.'